SCHEMBL7790594

SCHEMBL7790594

[CH2]CCC(=O)n1cnc2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ASAH1 Q13510 6/20 0.51
KMT2A Q03164 3/20 0.50
DNMT3A Q9Y6K1 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
EGLN3 Q9H6Z9 1/20 0.49
NPC1 O15118 2/20 0.48
ALDH1A1 P00352 1/20 0.48
MAPT P10636 1/20 0.48
HPGD P15428 1/20 0.48
RAB9A P51151 1/20 0.48
HSD17B10 Q99714 1/20 0.48
HTT P42858 1/20 0.48
LMNA P02545 1/20 0.47
STAT6 P42226 1/20 0.47
MEN1 O00255 1/20 0.47
TDP1 Q9NUW8 1/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17322551 0.83 EGLN3 (0.51) ASAH1KMT2ADNMT3ASMN1; SMN2EGLN3
SCHEMBL7132708 0.81 ASAH1 (0.55) ASAH1KMT2ADNMT3ASMN1; SMN2EGLN3
SCHEMBL11012986 0.80 NPC1 (0.57) ASAH1KMT2ADNMT3ASMN1; SMN2EGLN3
SCHEMBL13092515 0.79 ASAH1 (0.66) ASAH1KMT2ASMN1; SMN2EGLN3NPC1
SCHEMBL17309678 0.79 ASAH1 (0.47) ASAH1KMT2ADNMT3ASMN1; SMN2EGLN3
SCHEMBL13092517 0.79 ASAH1 (0.66) ASAH1KMT2ASMN1; SMN2EGLN3NPC1
SCHEMBL32660141 0.79 ASAH1 (0.52) ASAH1KMT2ADNMT3ASMN1; SMN2EGLN3
SCHEMBL593554 0.78 KMT2A (0.48) ASAH1KMT2ASMN1; SMN2EGLN3NPC1
SCHEMBL1735988 0.77 ASAH1 (0.55) ASAH1KMT2ADNMT3ASMN1; SMN2EGLN3
SCHEMBL11443588 0.77 KMT2A (0.60) ASAH1KMT2ADNMT3ASMN1; SMN2EGLN3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1155026-A2 METHOD FOR ISOLATING NUCLEIC ACIDS Bayer Aktiengesellschaft (DE) 2001-11-21 EP disclosed
WO-2000049031-A2 METHOD FOR ISOLATING NUCLEIC ACIDS BAYER AKTIENGESELLSCHAFT (DE) 2000-08-24 WO disclosed